A promising avenue for the treatment of MASH!
Have you heard of MASH ((Metabolic Associated SteatoHepatitis)? Previously known as NASH (Non-Alcoholic SteatoHepatitis). MASH, closely linked to obesity and type 2 diabetes epidemic, is…
"Promoting and supporting research into diabetes
and metabolic diseases".
For the advancement of diabetes research
The FFRD wishes you a wonderful holiday season!
It is with immense gratitude and sincere appreciation that we THANK YOU!
The FFRD wishes everyone a 2025 filled with joy, health, and success in your personal and professional endeavors..
THANK YOU FOR STANDING WITH US IN THIS ESSENTIAL FIGHT!
Have you heard of MASH ((Metabolic Associated SteatoHepatitis)? Previously known as NASH (Non-Alcoholic SteatoHepatitis). MASH, closely linked to obesity and type 2 diabetes epidemic, is…
Diabetes mellitus affects 5% of the French population and is a major burden for the persons living with this chronic disease, with potentially serious complications and high costs induced. Major and continuous improvements have been made for a botter understanding of the mechanisms of the disease and its complications, and for its monitoring and treatment as well.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been: